Home
Conditions
Genital Neoplasms, Female

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,589 public trials 1,039 recruiting studies

Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Recruiting

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

NCT06926075

Conditions: Adnexal Diseases, Astrocytoma, Breast Cancer, +47 more
Locations: St George Private Hospital Kogarah, New South Wales, Australia

South Western Sydney Local Health District Liverpool, New South Wales, Australia

Southside Cancer Centre Miranda, New South Wales, Australia

View Trial Details

Recruiting

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

NCT07472140

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: N.N. Alexandrov National Caner Centre Minsk, Lesnoy, Belarus

View Trial Details

Recruiting

MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer

NCT06483048

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +30 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Recruiting

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

NCT07470853

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +18 more
Locations: University of Arkansas - Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States

START - Los Angeles Los Angeles, California, United States

SCRI - Florida Cancer Specialists Sarasota, Florida, United States

St. Francis Medical Center (OSF Healthcare) Peoria, Illinois, United States

View Trial Details

Recruiting

A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks

NCT07469709

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +46 more
Locations: Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo Candiolo, Turin, Italy

View Trial Details

Recruiting

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

NCT07050771

Conditions: Adnexal Diseases, Bladder Cancer, Endocrine Gland Neoplasms, +23 more
Locations: Houston Methodist Neal Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

NCT06349642

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +83 more
Locations: Mayo Clinic in Arizona Phoenix, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

Point of Care - Triage and Treatment for Cervical Pre-cancer

NCT07461818

Conditions: Cervical Intraepithelial Neoplasia, Cervical Precancer, Communicable Diseases, +26 more
Locations: Basic Health International San Salvador, San Salvador Department, El Salvador

View Trial Details

Recruiting

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

NCT03968406

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +46 more
Locations: Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States

M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer

NCT07460180

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: NKI-AvL Amsterdam, Netherlands

View Trial Details

Genital Neoplasms, Female

Genital Neoplasms, Female trial results

Related conditions